Edgewise Therapeutics Inc’s recent filing unveils that its Chief Scientific Officer Russell Alan J unloaded Company’s shares for reported $0.24 million on Feb 05 ’25. In the deal valued at $30.02 per share,8,015 shares were sold. As a result of this transaction, Russell Alan J now holds 14,863 shares worth roughly $0.39 million.
Then, Russell Alan J sold 1,200 shares, generating $36,153 in total proceeds. Upon selling the shares at $30.13, the Chief Scientific Officer now owns 14,863 shares.
Before that, KOCH KEVIN sold 8,636 shares. Edgewise Therapeutics Inc shares valued at $259,298 were divested by the President and CEO at a price of $30.03 per share. As a result of the transaction, KOCH KEVIN now holds 14,478 shares, worth roughly $0.38 million.
Stifel initiated its Edgewise Therapeutics Inc [EWTX] rating to a Hold in a research note published on January 22, 2025; the price target was $30. A number of analysts have revised their coverage, including Evercore ISI’s analysts, who began to cover the stock in late November with a ‘”an Outperform”‘ rating. Piper Sandler began covering EWTX with “an Overweight” recommendation on March 07, 2024. Truist started covering the stock on May 01, 2023. It rated EWTX as “a Buy”.
Price Performance Review of EWTX
On Tuesday, Edgewise Therapeutics Inc [NASDAQ:EWTX] saw its stock fall -0.68% to $26.16. Over the last five days, the stock has lost -11.32%. Edgewise Therapeutics Inc shares have fallen nearly -2.02% since the year began. Nevertheless, the stocks have risen 32.05% over the past one year. While a 52-week high of $38.12 was reached on 02/06/25, a 52-week low of $14.90 was recorded on 01/13/25. SMA at 50 days reached $28.64, while 200 days put it at $24.25.
Levels Of Support And Resistance For EWTX Stock
The 24-hour chart illustrates a support level at 25.53, which if violated will result in even more drops to 24.91. On the upside, there is a resistance level at 26.54. A further resistance level may holdings at 26.93. The Relative Strength Index (RSI) on the 14-day chart is 41.35, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -1.62, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 83.24%. Stochastics %K at 10.87% indicates the stock is a buying.
How much short interest is there in Edgewise Therapeutics Inc?
A steep rise in short interest was recorded in Edgewise Therapeutics Inc stocks on 2025-01-31, growing by 0.91 million shares to a total of 7.06 million shares. Yahoo Finance data shows the prior-month short interest on 2024-12-31 was 6.14 million shares. There was a rise of 12.95%, which implies that there is a positive sentiment for the stock.
